Latest Articles
“I Dismissed It as Menopause”—One Woman’s Endometrial Cancer Story - Chatelaine
“I Dismissed It as Menopause”—One Woman’s Endometrial Cancer Story Chatelaine
Published: June 9, 2026, 7:04 p.m.
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years - MSN
The RUBY trial: For certain patients, immunotherapy-chemo combination keeps advanced endometrial cancer from progressing for years MSN
Published: June 8, 2026, 8:37 p.m.
RUBY Trial Suggests Some Patients With Advanced Endometrial Cancer May Be Living Cancer-Free for Years - SurvivorNet
RUBY Trial Suggests Some Patients With Advanced Endometrial Cancer May Be Living Cancer-Free for Years SurvivorNet
Published: June 8, 2026, 8:12 p.m.
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease - The ASCO Post
Mali Barbi, MD, MS, on Endometrial Cancer: Data in dMMR Disease and B7-H4 ADCs for Advanced Disease The ASCO Post
Published: June 8, 2026, 4:29 p.m.
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype - Oncodaily
Mali Barbi: ASCO 2026 Endometrial Cancer Recap Highlights Potential Curative Signal in dMMR Subtype Oncodaily
Published: June 7, 2026, 6:12 a.m.
Ramez N. Eskander, MD, on Endometrial Cancer: Pembrolizumab Plus Carboplatin/Paclitaxel - The ASCO Post
Ramez N. Eskander, MD, on Endometrial Cancer: Pembrolizumab Plus Carboplatin/Paclitaxel The ASCO Post
Published: June 5, 2026, 2:51 a.m.
Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer - The ASCO Post
Noelle Cloven, MD, on RAINFOL-03: Actively Recruiting Trial in Pretreated Endometrial Cancer The ASCO Post
Published: June 4, 2026, 10:12 p.m.
KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption - TradingView
KPTI: Phase III data in myelofibrosis and endometrial cancer signal major advances and rapid adoption TradingView
Published: June 4, 2026, 1:28 p.m.
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 - Karyopharm
Karyopharm to Participate in Webcast Featuring Endometrial Cancer Key Opinion Leader on June 8, 2026 Karyopharm
Published: June 3, 2026, 10:53 p.m.
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study - apd.cat
The same molecular group that slows colorectal cancer drives endometrial cancer in a Lleida study apd.cat
Published: June 3, 2026, 3:47 p.m.
Link copied to clipboard!